| Literature DB >> 22119370 |
Graham W Warren1, Susanne M Arnold, Joseph P Valentino, Thomas J Gal, Andrew J Hyland, Anurag K Singh, Vivek M Rangnekar, K Michael Cummings, James R Marshall, Mahesh R Kudrimoti.
Abstract
Prospective analysis was performed of self-reported and biochemically confirmed tobacco use in 50 head and neck cancer patients during treatment. With 93.5% compliance to complete weekly self-report and biochemical confirmatory tests, 29.4% of smokers required biochemical assessment for identification. Accuracy increased by 14.9% with weekly vs. baseline self-reported assessments. Data confirm that head and neck cancer patients misrepresent true tobacco use during treatment.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22119370 PMCID: PMC3327779 DOI: 10.1016/j.radonc.2011.11.003
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280